


Healthcare News Roundup: Generic Pharmaceuticals
HSMN NewsFeed - 28 Nov 2006
Abraxis BioScience Receives FDA Approval for Ampicillin and Sulbactam for Injection, 15g, USP
Abraxis BioScience Receives FDA Approval for Ampicillin and Sulbactam for Injection, 15g, USP
HSMN NewsFeed - 17 Nov 2006
Fougera Receives Approval for First Generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx)
Fougera Receives Approval for First Generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx)
HSMN NewsFeed - 15 Nov 2006
Cobalt Announces Settlement of Imitrex(R) Litigation With GlaxoSmithKline
Cobalt Announces Settlement of Imitrex(R) Litigation With GlaxoSmithKline
HSMN NewsFeed - 13 Nov 2006
Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation
Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation
HSMN NewsFeed - 13 Nov 2006
Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
HSMN NewsFeed - 10 Nov 2006
IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg
IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg
HSMN NewsFeed - 10 Nov 2006
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets
HSMN NewsFeed - 2 Nov 2006
Ranbaxy Receives Tentative Approval to Manufacture and Market Cetirizine Hydrochloride Syrup
Ranbaxy Receives Tentative Approval to Manufacture and Market Cetirizine Hydrochloride Syrup
HSMN NewsFeed - 1 Nov 2006
Synovics Pharmaceuticals Initiates U.S. Development of Its Fourth Generic Oral Controlled-Release Drug
Synovics Pharmaceuticals Initiates U.S. Development of Its Fourth Generic Oral Controlled-Release Drug
HSMN NewsFeed - 23 Oct 2006
U.S. Appeals Court Denies Ranbaxy Petition for Rehearing Regarding Main Patent in Lipitor Case
U.S. Appeals Court Denies Ranbaxy Petition for Rehearing Regarding Main Patent in Lipitor Case
HSMN NewsFeed - 20 Oct 2006
Barr Acquires PLIVA d.d. Following Official Closing of Tender Offer Process
Barr Acquires PLIVA d.d. Following Official Closing of Tender Offer Process
